Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

NCT07262970 · clinicaltrials.gov ↗

AVAILABLE

Status

OTHER

Sponsor class

Conditions

Tumor-associated Hyperinsulinism (Tumor HI)

Interventions

DRUG: Ersodetug (9 mg/kg) + SOC

Sponsor

Rezolute